¿Cuál es el protocolo de actuación ante un shock?
Protocolo de actuación Shok 2026 en idioma español
I cannot determine what “Shok 2026” refers to (e.g., a specific hospital/network document, a regional EMS algorithm, or a branded protocol). If you share the issuing organization/country and a link or PDF title, I can help summarize and critically appraise it. Also, I can only provide responses in English.
Executive summary (evidence-based “adult shock” action protocol, usable as a 2026 template)
Across etiologies, early shock care should prioritize (1) rapid recognition and phenotyping, (2) immediate stabilization of airway/oxygenation and perfusion, and (3) cause-directed therapy in parallel with resuscitation, because delay in definitive therapy (e.g., antibiotics/source control in septic shock; reperfusion in AMI-related shock) worsens outcomes SSC 2021 [1] ESC ACS 2023 [2]. For septic shock, current high-level guidance supports early antimicrobials, early fluids, and norepinephrine-first vasopressor strategy with a pragmatic MAP target around 65 mmHg in most adults SSC 2021 [1]. For AMI-related cardiogenic shock, management is anchored in urgent coronary revascularization strategy and selective escalation to mechanical circulatory support; routine IABP has not shown mortality benefit ESC ACS 2023 [2] NEJM 2012 IABP-SHOCK II [3].
1) First 5–10 minutes: universal stabilization
- rapid phenotyping
Primary goals: prevent immediate death from hypoxemia/airway failure, and restore perfusion while identifying the dominant shock phenotype (distributive vs cardiogenic vs hypovolemic vs obstructive; mixed forms are common) SSC 2021 [1].
Actions (performed in parallel):
- A/B: airway assessment; oxygen; ventilatory support if needed to reduce work of breathing and improve oxygen delivery (context-dependent) SSC 2021 [1].
- C: continuous ECG, BP (consider arterial line early in unstable patients), pulse oximetry; obtain large-bore IV access; draw labs including lactate, CBC, CMP, coagulation, ABG/VBG as available SSC 2021 [1].
- Focused bedside evaluation (history, exam, ECG, point-of-care ultrasound if available) to rapidly separate likely septic shock vs AMI-related cardiogenic shock and trigger the appropriate pathway early SSC 2021 [1] ESC ACS 2023 [2].
Clinical decision point: if hypotension is severe and persistent, initiate vasopressors promptly (even via a well-functioning peripheral line as a bridge, per local policy) rather than waiting for prolonged fluid administration—particularly when cardiogenic shock is plausible or fluid intolerance is likely SSC 2021 [1].
2) Septic shock pathway (when distributive shock is most likely)
Trigger: suspected/confirmed infection + vasopressor requirement to maintain perfusion and/or signs of hypoperfusion; treat as time-critical SSC 2021 [1].
Core bundle elements (adult):
- Antibiotics: administer promptly after cultures if this does not meaningfully delay therapy; urgency is highest in septic shock SSC 2021 [1].
- Fluids: crystalloid resuscitation early; the common initial approach is ~30 mL/kg in the first hours in patients with hypoperfusion, but SSC emphasizes individualized reassessment and acknowledges uncertainty/heterogeneity in fluid responsiveness and harms (especially in HF/CKD) SSC 2021 [1].
- Vasopressors: norepinephrine first-line to target a MAP ~65 mmHg for most adults, then titrate to organ perfusion; add a second agent (e.g., vasopressin) when escalating norepinephrine or to reduce catecholamine exposure (strategy individualized) SSC 2021 [1].
- Reassessment: repeated evaluation of perfusion (mental status, capillary refill, urine output) and lactate trends to guide ongoing resuscitation and avoid iatrogenic fluid overload SSC 2021 [1].
- Source control: identify and control the source as soon as feasible (drainage, surgery, device removal), coordinated with hemodynamic stabilization SSC 2021 [1].
Key uncertainty (clinically important): outside of “early rescue” resuscitation, the optimal fluid strategy (volume, rate, dynamic measures) is not one-size-fits-all; SSC recommendations include multiple “suggestions” rather than uniformly strong directives, reflecting limited certainty in several domains SSC 2021 [1].
3) AMI-related cardiogenic shock pathway (when cardiogenic shock is most likely)
Trigger: shock with evidence of ACS/AMI or acute pump failure; treat as a systems-of-care emergency with early cardiology/ICU involvement (“shock team” model where available) ESC ACS 2023 [2].
Core actions:
- Immediate reperfusion strategy: urgent invasive evaluation and revascularization planning per ACS guidance; in AMI with multivessel disease and shock, an initial strategy focusing on the culprit lesion (with possible staged non-culprit PCI) is supported in contemporary ESC guidance ESC ACS 2023 [2].
- Mechanical support (principles):
- Do not use IABP routinely in AMI-related cardiogenic shock, as randomized evidence did not show mortality benefit when added to early revascularization strategies NEJM 2012 IABP-SHOCK II [3].
- Escalation to other temporary mechanical circulatory support should be individualized (phenotype, severity, complications, local expertise). Comparative superiority across devices should not be assumed without head-to-head randomized evidence in the same phenotype.
- Hemodynamic strategy: vasopressors/inotropes are typically used to maintain perfusion while definitive therapy proceeds; selection and titration are guided by BP, congestion, lactate, echo findings, and (in many centers) invasive hemodynamics ESC ACS 2023 [2].
Key uncertainty (clinically important): cardiogenic shock is highly heterogeneous (LV failure, RV failure, mechanical complications, mixed distributive components post-arrest), so protocolized “one device/one drug” approaches are risky; local pathways should explicitly define eligibility criteria for escalation and mandatory reassessment checkpoints ESC ACS 2023 [2].
4) Practical reassessment checkpoints (applies to all shock phenotypes)
At minimum, reassess every 10–15 minutes during active resuscitation and after each intervention (fluid bolus, vasopressor titration, ventilation change), using a consistent set of endpoints to avoid “treating the number” alone SSC 2021 [1]:
- Perfusion: mental status, skin temperature/mottling, capillary refill, urine output.
- Hemodynamics: MAP and pulse pressure trends; consider dynamic tests of fluid responsiveness where feasible.
- Metabolic: lactate trend (interpret in clinical context; non-hypoperfusion causes exist).
What I need from you to provide the exact “Shok 2026” protocol in Spanish
Please paste the cover page text or share: (1) the issuing institution/region, (2) whether this is prehospital EMS vs ED/ICU, and (3) the shock type focus (septic vs cardiogenic vs trauma). Then I can (a) extract the steps, (b) check them against guideline-level evidence, and (c) highlight decision points, contraindications, and where the protocol is strong vs uncertain using only high-quality sources such as SSC and ESC guidance SSC 2021 [1] ESC ACS 2023 [2].
Fuentes
- https://www.sccm.org/clinical-resources/guidelines/guidelines/surviving-sepsis-guidelines-2021
- https://sochicar.cl/wp-content/uploads/2023/09/ehad191.pdf
- https://www.tkdcd.org/public/uploads/files/pdf/randomize_klinik_calismalar/2012_SHOCKII_Intraaortic-Balloon-Support-for-Myocardial-Infarction-with-Cardiogenic-Shock_NEJM.pdf
- https://aftershockfestival.com
- https://manualclinico.hospitaluvrocio.es/urgencias/emergencias-generales/shock/
- https://lol.fandom.com/wiki/Shok
- https://www.youtube.com/watch?v=zB3GzYrLUqM
- https://www.osakidetza.euskadi.eus/contenidos/informacion/gidep_epdt/es_def/adjuntos/gidep_shock.pdf
- https://music.amazon.com/en-cl/artists/B0016SKDTI/shok
- https://elcomercio.pe/politica/elecciones/elecciones-2026-fiscalia-de-la-nacion-aprueba-su-protocolo-para-actuacion-funcional-en-procesos-de-eleccion-de-autoridades-ultimas-noticia/
- https://lol.fandom.com/wiki/Shok/Statistics
- https://www.escardio.org/education/content-collections/focus/cardiogenic-shock-and-acute-mechanical-circulatory-support/
- https://emcrit.org/emcrit/2025-aha-acls-guidelines/
- https://sccm.org/survivingsepsiscampaign/guidelines-and-resources/surviving-sepsis-campaign-adult-guidelines
- https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2023/12/21/16/43/2023-aha-adult-acls
- https://www.escardio.org/guidelines/clinical-practice-guidelines/all-esc-practice-guidelines/acute-coronary-syndromes-acs-guidelines/
- https://www.mcmasteroptimalaging.org/full-article/plus/2023-american-heart-association-focused-update-adult-advanced-cardiovascular-111814
- https://www.idsociety.org/practice-guideline/surviving-sepsis-campaign-adult-guidelines-2021/
- https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2023/12/21/16/43/2023-aha-adult-acls
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10246868/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9088333/
- https://www.acc.org/latest-in-cardiology/clinical-trials/2024/04/05/04/44/danger-shock
- https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2017/10/27/16/10/CULPRIT-SHOCK
- https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2014/05/14/22/54/IABP-SHOCK-II
- https://pubmed.ncbi.nlm.nih.gov/41007760/
- https://www.acc.org/latest-in-cardiology/articles/2018/01/22/09/02/important-trial-results-for-interventional-cardiology-from-tct-2017-and-aha-2017
- https://pubmed.ncbi.nlm.nih.gov/22709745/
- https://www.acc.org/latest-in-cardiology/articles/2024/04/02/17/02/sun-945am-danger-shock-acc-2024
- https://pubmed.ncbi.nlm.nih.gov/28821512/
- https://www.acc.org/Latest-in-Cardiology/Articles/2012/07/24/11/55/ESC-IABP-SHOCK-II
- https://www.abiomed.com/en-us/about-us/news-and-media/press-releases/rct-confirms-impella-cp-improves-survival-in-heart-attack-with-cs
- https://pubmed.ncbi.nlm.nih.gov/30586721/
- https://www.crf.org/crf/news-and-events/news/news/2485-should-patients-with-cardiogenic-shock-receive-culprit-lesion-only-pci-or-multivessel-pci
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6940235/
- https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/04/05/04/44/danger-shock
- https://www.acc.org/latest-in-cardiology/clinical-trials/2017/10/27/16/10/culprit-shock
- https://www.thebottomline.org.uk/summaries/danger-shock-microaxial-flow-pump-in-infarct-related-cardiogenic-shock/
- https://www.dicardiology.com/content/culprit-lesion-only-pci-improves-outcomes-cardiogenic-shock-patients-compared-multivessel
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6560613/
- https://pubmed.ncbi.nlm.nih.gov/38587239/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9725066/
- https://www.acc.org/Latest-in-Cardiology/Articles/2017/10/26/12/55/mon-1pm-culprit-shock-tct-2017
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6415997/
- https://pubmed.ncbi.nlm.nih.gov/32883104/
- https://pubmed.ncbi.nlm.nih.gov/37622654/
Respuesta generada por inteligencia artificial a partir de las fuentes citadas. Verifica las fuentes antes de aplicarla.